Adenosine in the treatment of supraventricular tachycardia
First Claim
Patent Images
1. A method of treating supraventricular tachycardia caused by re-entry in the AV node, comprising the steps of:
- (a) administering intravenously to a human afflicted with the tachycardia, 0.01-0.25 mg/kg of body weight of adenosine sufficient to restore normal rhythm.
2 Assignments
0 Petitions
Accused Products
Abstract
A method of diagnosing and treating arrhythmias caused by re-entry in the A-V node by administering to a human or animal an effective amount of adenosine that restores normal sinus rhythm.
-
Citations
10 Claims
-
1. A method of treating supraventricular tachycardia caused by re-entry in the AV node, comprising the steps of:
(a) administering intravenously to a human afflicted with the tachycardia, 0.01-0.25 mg/kg of body weight of adenosine sufficient to restore normal rhythm. - View Dependent Claims (2, 3, 4, 5)
-
6. A method of diagnosing supraventricular tachycardia caused by re-entry in the AV node, comprising the steps of:
-
(a) administering intravenously to a human afflicated with the tachycardia 0.01-0.25 mg/kg of body weight of adenosine; (b) monitoring the heart beat of said human for restoration of normal sinus rhythm; and (c) determining the existence of the tachycardia. - View Dependent Claims (7, 8, 9, 10)
-
Specification